Select Page

Anti-Human CD8a FITC (Monoclonal Antibody)

This product is only available in the US
FP10605010
Antibody
100 Tests

$169.50

DATA SHEET

The RPA-T8 monoclonal antibody specifically reacts with the human CD8a molecule, a 32 kDa cell surface receptor expressed either as a heterodimer (CD8 α/β) or as a homodimer (CD8 α/α) on the majority of thymocytes, a subpopulation of mature T cells, and natural killer cells. CD8 interacts with the major histocompatibility complex class I (MHC class I) molecules on antigen-presenting cells or epithelial cells. The RPA-T8 antibody reacts with 13-48% of peripheral lymphocytes, 80% of thymocytes, and a subset of natural killer cells.

RPA-T8, OKT8, and HIT8a antibodies do not compete with each other for binding to peripheral leukocytes, meaning that that they do not recognize the same epitope or block each other by steric hindrance.

Product TypeAntibody
ApplicationFCM
ConjugateFITC
IsotypeIgG1 ĸ
Species ReactivityHuman
FormulationPhosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.
Storage TemperatureProduct should be kept at 2-8°C and protected from prolonged exposure to light
ProtocolsFCM
Clone NumberRPA-T8
Concentration5 µL (1 µg)/test
Regulatory StatementFor Research Use Only. Not for use in diagnostic procedures.
This product is only available in the US
FP10605010
Antibody
100 Tests

$169.50

Related Content

SIGN UP